Provided by Tiger Trade Technology Pte. Ltd.

Twist Bioscience Corp

139.00
-2.3800-1.68%
Pre-market: 136.99-2.0100-1.45%06:30 EDT
Volume:1.89M
Turnover:260.78M
Market Cap:8.72B
PE:-62.35
High:140.60
Open:139.99
Low:135.00
Close:141.38
52wk High:155.44
52wk Low:23.30
Shares:62.71M
Float Shares:61.76M
Volume Ratio:1.22
T/O Rate:3.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.2293
EPS(LYR):-1.2987
ROE:-29.59%
ROA:-13.09%
PB:19.55
PE(LYR):-107.03

Loading ...

Twist Bioscience Corp : TD Cowen Raises Target Price to $89 From $68

THOMSON REUTERS
·
Jun 15

Intel, SMCI, SpaceX, Twist, Adobe Trending With Analysts

TIPRANKS
·
Jun 13

Movement Alert|Twist Bioscience Corp Rises 8.88% in Regular Trading, Trading at $73.705

Market Focus
·
Jun 12

Twist Bioscience Initiated at Overweight by Piper Sandler

Dow Jones
·
Jun 11

Twist Bioscience Chief Legal Officer Dennis Cho sells 14,205 shares worth $990,798.75

Reuters
·
Jun 03

Twist Bioscience CFO Adam Laponis disposes of 4,000 shares worth $280,000

Reuters
·
Jun 03

A Look At Twist Bioscience (TWST) Valuation After A Strong Multi Year Share Price Run

Simply Wall St.
·
Jun 03

Twist Bioscience posts investor presentation on DNA synthesis platform, growth strategy

Reuters
·
Jun 02

Twist Bioscience director Melissa A. Starovasnik sells 2,500 shares for $170,000

Reuters
·
Jun 02

Twist Bioscience CEO Emily Leproust disposes of 16,470 shares worth $1,113,147.49

Reuters
·
Jun 02

Twist Bioscience director Melissa A. Starovasnik disposes of 500 common shares for $30,520

Reuters
·
May 29

Twist Bioscience CEO Emily Leproust sells 49,299 shares for $3.22 million

Reuters
·
May 29

Twist Bioscience to present at William Blair Growth Stock Conference

Reuters
·
May 27

Stock Track | Twist Bioscience Soars 5.02% Intraday on Barclays' Bullish Buy Rating

Stock Track
·
May 26

Barclays Remains a Buy on Twist Bioscience (TWST)

TIPRANKS
·
May 26

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
May 24

Twist Bioscience Corp : Leerink Partners Raises Target Price to $80 From $70

THOMSON REUTERS
·
May 22

Twist Bioscience guides FY26 revenue at $442-$447 million

Reuters
·
May 22

Twist Bioscience Chief Accounting Officer Robert F. Werner sells shares worth $282,207.72

Reuters
·
May 13

Leniobio and Twist Bioscience Enter Into a Collaboration to Further Enable AI Drug-Discovery

THOMSON REUTERS
·
May 08